A new endothelial target for cannabinoids

Molecular Pharmacology

Volumn 63, Issue 3, 2003, Pages 469-470

  Randall, Michael D ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CANNABIDIOL DERIVATIVE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; DRONABINOL; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; O 1918; POTASSIUM CHANNEL; RIMONABANT; UNCLASSIFIED DRUG; VANILLOID RECEPTOR;

BRAIN CIRCULATION; BRAIN PERFUSION; DRUG RECEPTOR BINDING; DRUG TARGETING; GAP JUNCTION; HYPERPOLARIZATION; MOUSE; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASODILATATION;

ANIMALS; ARACHIDONIC ACIDS; BIOLOGICAL FACTORS; ENDOCANNABINOIDS; ENDOTHELIUM, VASCULAR; FATTY ACIDS, UNSATURATED; HUMANS; POLYUNSATURATED ALKAMIDES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0037334441     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.63.3.469     Document Type: Review

References (16)

1. Chaytor AT, Martin PEM, Evans WH, Randall MD, and Griffith TM (1999) The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication. J Physiol (Lond) 520:539-550.
2. Deutsch DG, Goligorsky MS, Schmid PG, Krebsbach RJ, Schmid HHO, Das SK, Dey SK, Arreaza G, Thorup C, Stefano G, and Moore LC (1997) Production and physiological actions of anandamide in the vasculature of the rat kidney. J Clin Investig
3. 9THC dilation of cerebral arterioles is blocked by indomethacin. Am J Physiol 38:H1859-H1864.
4. Fleming I, Schermer B, Popp R, and Busse R (1999) Inhibition of the production of endothelium-derived hyperpolarizing factor by cannabinoid receptor agonists. Br J Pharmacol 126:949-960.
5. 2+ channel current. Am J Physiol 45:H2085-H2093.
6. Hillard CJ (2000) Endocannabinoids and vascular function. J Pharmacol Exp Ther 294:27-32.
7. 2 receptors. Proc Natl Acad Sci 96:14136-14141.
8. 1 receptor knockout mice. Science (Wash) 283:401-404.
9. Liu J, GaoB, Mirshahi F, Sanyal AJ, Khanolkar AD, Makriyannis A, and Kunos G (2000) Functional CB1 cannabinoid receptors in human vascular endothelial cells. Biochem J 346:835-840.
10. Mukhopadhyay S, Chapnick BM, and Howlett AC (2002) Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent. Am J Physiol 282:H2046-H2054.
11. Pratt PF, Hillard CJ, Edgemond WS, and Campbell WB (1998) N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. Am J Physiol 43:H375-H381.
12. Ralevic V, Kendall DA, Randall MD, and Smart D (2002) Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function. Life Sci 71:2577-2594.
13. Randall MD, Alexander SPH, Bennett T, Boyd EA, Fry JR, Gardiner SM, Kemp PA, McCulloch AI, and Kendall DA (1996) An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem Biophys Res Commun 229:114-120.
14. Randall MD, Harris D, Kendall DA, and Ralevic V (2002) Cardiovascular effects of cannabinoids. Pharmacol Ther 95:191-202.
15. Randall MD, McCulloch AI, and Kendall DA (1997) Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery. Eur J Pharmacol 333:191-197.
16. Zygmunt PM, Petersson J, Andersson DA, Chuang H-h, Sorgard M, Di Marzo V, Julius D, and Hogestatt ED (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature (Lond) 400:452-457.